Record NNP B-NP O
date NN I-NP O
: : O O
2124-03-04 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
C NNP I-NP O
Admission NNP I-NP O
Note NNP I-NP O
PATIENT NNP B-NP O
: : O O
Veda NNP B-NP B-PATIENT
Edgar NNP I-NP I-PATIENT
MRN NNP B-NP O
: : O O
9262764 CD O B-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
3/4/2124 CD O B-DATE
ATTENDING NN B-NP O
: : O O
Brenda NNP B-NP B-DOCTOR
Youmans NNP I-NP I-DOCTOR
( -LRB- I-NP O
ward NN I-NP O
) -RRB- O O
PCP NN B-NP O
: : O O
Arthur NNP B-NP B-DOCTOR
Qin NNP I-NP I-DOCTOR
Code NNP B-NP O
status NN I-NP O
: : O O
FULL NNP B-NP O
( -LRB- B-VP O
per FW B-NP O
chart NN I-NP O
) -RRB- O O
Sources NNS B-NP O
: : O O
Patient NNP B-NP O
, , O O
daughter NN B-NP O
, , O O
chart NN B-NP O
CC NNP B-NP O
: : O O
Persistent JJ B-NP O
cough NN I-NP O
HPI NNP B-NP O
: : O O
Ms. NNP B-NP O
Edgar NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
64 CD I-NP B-AGE
year-old JJ I-NP O
frequently RB I-NP O
hospitalized VBN I-NP O
woman NN I-NP O
with IN B-PP O
CHFpEF NNP B-NP O
( -LRB- I-NP O
EF NN I-NP O
= SYM O O
71 CD B-NP O
% NN I-NP O
) -RRB- I-NP O
, , O O
COPD NNP B-NP O
on IN B-PP O
2.5L JJ B-NP O
home NN I-NP O
O2 NNS I-NP O
and CC O O
chronic NN B-NP O
steroids NNS I-NP O
( -LRB- B-VP O
currently RB B-NP O
10 CD I-NP O
mg JJ I-NP O
prednisone NN I-NP O
) -RRB- I-NP O
, , O O
OSA NNP B-NP O
on IN B-PP O
BiPAP NNP B-NP O
, , O O
CKD NNP B-NP O
, , O O
and CC O O
chronic JJ B-NP O
pain NN I-NP O
on IN B-PP O
chronic JJ B-NP O
narcotics NNS I-NP O
, , O O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
persistent JJ B-NP O
cough NN I-NP O
productive JJ B-ADJP O
of IN B-PP O
green NN B-NP O
sputum NN I-NP O
after IN B-PP O
recently RB B-ADVP O
being VBG B-VP O
treated VBN I-VP O
for IN B-PP O
influenza NN B-NP O
. . O O
According VBG B-PP O
to TO B-PP O
the DT B-NP O
patient NN I-NP O
, , O O
she PRP B-NP O
left VBD B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
completed VBD B-VP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
Tamiflu NNP B-NP O
and CC O O
azithromycin RB B-ADVP O
on IN B-PP O
2/24 CD B-NP B-DATE
, , O O
and CC O O
continued VBD B-VP O
to TO I-VP O
feel VB I-VP O
poorly RB B-ADVP O
, , O O
with IN B-PP O
a DT B-NP O
chronic JJ I-NP O
nagging JJ I-NP O
cough NN I-NP O
that WDT B-NP O
was VBD B-VP O
productive JJ B-ADJP O
of IN B-PP O
dark JJ B-NP O
green JJ I-NP O
sputum NN I-NP O
. . O O
No DT B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
sweats VBZ B-VP O
, , O O
myalgias NNS B-NP O
, , O O
or CC O O
SOB. NNP B-NP O
Yesterday NN I-NP O
, , O O
she PRP B-NP O
developed VBD B-VP O
worsening VBG I-VP O
pain NN B-NP O
, , O O
especially RB B-ADVP O
in IN B-PP O
her PRP$ B-NP O
ribs NNS I-NP O
, , O O
extending VBG B-VP O
across IN B-PP O
the DT B-NP O
anterior JJ I-NP O
surface NN I-NP O
; : O O
she PRP B-NP O
said VBD B-VP O
the DT B-NP O
pain NN I-NP O
is VBZ B-VP O
worse JJR B-ADJP O
with IN B-PP O
movement NN B-NP O
but CC O O
does VBZ B-VP O
not RB I-VP O
vary VB I-VP O
with IN B-PP O
respiration NN B-NP O
or CC I-NP O
cough NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
unable JJ B-ADJP O
to TO B-VP O
ambulate VB I-VP O
, , O O
as IN B-SBAR O
she PRP B-NP O
states VBZ B-VP O
she PRP B-NP O
does VBZ B-VP O
at IN B-PP O
baseline NN B-NP O
with IN B-PP O
a DT B-NP O
walker NN I-NP O
. . O O
This DT B-NP O
is VBZ B-VP O
her PRP$ B-NP O
tenth JJ I-NP O
hospital NN I-NP O
and CC I-NP O
fourteenth JJ I-NP O
ED JJ I-NP O
visit NN I-NP O
to TO B-VP O
MCH VB I-VP B-HOSPITAL
in IN B-PP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
( -LRB- O O
there EX B-NP O
are VBP B-VP O
records NNS B-NP O
in IN B-PP O
the DT B-NP O
chart NN I-NP O
of IN B-PP O
OSH NNS B-NP O
visits NNS I-NP O
as RB B-CONJP O
well RB I-CONJP O
) -RRB- I-CONJP O
. . B-NP O
On IN B-PP O
interview NN B-NP O
she PRP B-NP O
is VBZ B-VP O
tearful JJ B-ADJP O
regarding VBG B-VP O
her PRP$ B-NP O
readmission NN I-NP O
, , O O
stating VBG B-VP O
that IN B-SBAR O
she PRP B-NP O
&#8220;tries VBZ B-VP O
so RB B-ADJP O
hard&#8221 JJ I-ADJP O
; : O O
to TO B-VP O
stay VB I-VP O
out IN B-ADVP O
of IN B-PP O
the DT B-NP O
hospital NN I-NP O
, , O O
&#8220;but CC O O
what WP B-NP O
am VBP B-VP O
I PRP B-NP O
supposed VBD B-VP O
to TO I-VP O
do VB I-VP O
when WRB B-ADVP O
I PRP B-NP O
am VBP B-VP O
sick JJ B-ADJP O
? . O O
&#8221 '' O O
; : O O
ED VBN B-NP O
Course NNP I-NP O
: : O O
In IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
a DT B-NP O
CXR NN I-NP O
showed VBD B-VP O
a DT B-NP O
RLL NNP I-NP O
patchy JJ I-NP O
opacity NN I-NP O
suggestive NN I-NP O
of IN B-PP O
pneumonia NN B-NP O
. . O O
She PRP B-NP O
received VBD B-VP O
750 CD B-NP O
mg NN I-NP O
levofloxacin NN I-NP O
, , O O
1 CD B-NP O
g NN I-NP O
vancomycin NN I-NP O
, , O O
nebulizer NN B-NP O
treatments NNS I-NP O
, , O O
and CC O O
morphine NN B-NP O
for IN B-PP O
pain NN B-NP O
control NN I-NP O
. . O O
ROS NNS B-NP O
On IN B-PP O
interview NN B-NP O
, , O O
she PRP B-NP O
endorses VBZ B-VP O
only RB B-NP O
rib JJ I-NP O
pain NN I-NP O
and CC O O
back NN B-NP O
and CC I-NP O
hip NN I-NP O
pain NN I-NP O
that IN B-SBAR O
she PRP B-NP O
says VBZ B-VP O
is VBZ B-VP O
chronic NN B-NP O
from IN B-PP O
her PRP$ B-NP O
spinal JJ I-NP O
stenosis NN I-NP O
. . O O
She PRP B-NP O
also RB B-ADVP O
complains VBZ B-VP O
of IN B-PP O
the DT B-NP O
chronic JJ I-NP O
cough NN I-NP O
described VBN B-VP O
above IN B-PP O
. . B-NP O
No DT I-NP O
CP NNPS I-NP O
, , O O
SOB NNP B-NP O
, , O O
dysuria NN B-NP O
, , O O
pyuria NN B-NP O
, , O O
N/V/D. . O O
MEDICAL/SURGICAL NNP B-NP O
HISTORY NN I-NP O
- : O O
Influenza NN B-NP O
: : O O
Recently RB B-VP O
discharged VBN I-VP O
on IN B-PP O
2/22/2124 CD B-NP B-DATE
after IN B-PP O
being VBG B-VP O
diagnosed VBN I-VP O
with IN B-PP O
influenza NN B-NP O
A. NN I-NP O
She PRP B-NP O
was VBD B-VP O
treated VBN I-VP O
with IN B-PP O
nebulizers NNS B-NP O
, , O O
tamiflu NN B-NP O
, , O O
and CC O O
azithromycin RB B-ADVP O
for IN B-PP O
5 CD B-NP O
days NNS I-NP O
. . O O
Spinal JJ B-NP O
stenosis NN I-NP O
and CC I-NP O
chronic NN I-NP O
back RB B-ADVP O
pain NN B-NP O
, , O O
on IN B-PP O
standing VBG B-NP O
narcotics NNS I-NP O
at IN B-PP O
home NN B-NP O
. . O O
Hospitalized VBN B-VP O
in IN B-PP O
January NNP B-NP O
for IN B-PP O
hypotension&#8212;-required JJ B-NP O
CCU NNP I-NP O
level NN I-NP O
of IN B-PP O
care NN B-NP O
; : O O
ultimately RB B-ADVP O
believed VBD B-VP B-DATE
to TO I-VP O
be VB I-VP O
secondary JJ B-ADJP O
to TO B-PP O
narcotics NNS B-NP O
overdose JJ B-ADJP O
. . O O
- : B-NP O
COPD NN I-NP O
: : O O
on IN B-PP O
2.L JJ B-NP O
home NN I-NP O
O2 IN B-PP O
with IN I-PP O
combined VBN B-NP O
obstructive/restrictive JJ I-NP O
component NN I-NP O
. . O O
PFTs '' O O
( -LRB- B-NP O
2122 CD I-NP O
) -RRB- I-NP O
: : O O
FEV1 JJ B-NP O
44 CD I-NP O
% NN I-NP O
pred VBN B-ADJP O
, , O O
FEV1/FVC NNP B-NP O
65 CD I-NP O
% NN I-NP O
pred VBD B-VP O
, , O O
DLCO NNP B-NP O
24 CD I-NP O
% NN I-NP O
pred VBN B-VP O
, , O O
no DT B-NP O
significant JJ I-NP O
bronchodilator NN I-NP O
response NN I-NP O
- : O O
HFpEF NN B-NP O
: : O O
TTE NNP B-NP O
7/2123 CD I-NP O
EF NNP I-NP O
71 CD I-NP O
% NN I-NP O
, , O O
no DT B-NP O
WMA NNP I-NP O
, , I-NP O
+RVH NNP I-NP O
, , I-NP O
unable JJ B-ADJP O
to TO B-VP O
estimate VB I-VP O
RVSP NNS B-NP O
- : O O
OSA NNS B-NP I-DATE
on IN B-PP I-DATE
home NN B-NP O
BiPAP . O O
- : O O
Morbidy JJ B-NP O
obesity NN I-NP O
with IN B-PP O
Obesity-Hypoventilation NNP B-NP O
Syndrome NNP I-NP O
- : B-NP O
NSCLC NNP I-NP O
: : O O
T1N0 CD B-NP O
s/p NN I-NP O
VATS NNS I-NP O
LLL JJ I-NP O
wedge NN I-NP O
resection NN I-NP O
( -LRB- I-NP O
2121 CD I-NP O
) -RRB- O O
- : O O
Recurrent JJ B-NP O
5-15mm JJ I-NP O
pulmonary NN I-NP O
nodules NNS I-NP O
by IN B-PP O
CT NNP B-NP O
4/2122 CD I-NP O
and CC I-NP O
3/2123 CD I-NP B-DATE
, , O O
being VBG B-VP O
followed VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Lacey NNP I-NP O
- : B-NP O
DVT/PE NN I-NP O
: : O O
4/2122 CD B-NP O
s/p NN I-NP O
treatment NN I-NP O
with IN B-PP O
Coumadin NNP B-NP O
which WDT B-NP O
was VBD B-VP O
discontinued VBN I-VP O
on IN B-PP O
3/2123 CD B-NP O
admission NN I-NP O
due JJ B-ADJP O
to TO B-VP O
fall VB I-VP O
risk NN B-NP O
concerns NNS I-NP O
. . O O
D-Dimer NN B-VP O
at IN B-PP O
that DT B-NP O
time NN I-NP O
1295 CD O O
- : O O
HTN NN B-NP O
- : O O
DM2 NN B-NP O
on IN B-PP O
Insulin NNP B-NP O
- : O O
Strabismus NN B-NP O
- : O O
Depression NN B-NP O
- : O O
Diverticulosis NN B-VP O
w/ NN B-NP O
h/o NN I-NP O
diverticulitis NN I-NP O
s/p NN I-NP O
colectomy NN I-NP O
- : O O
Hypothyroidism NN B-NP O
- : O O
Endometrial JJ B-NP B-DATE
hyperplasia NN I-NP O
- : O O
Microcytic NNP B-NP O
anemia NN I-NP O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Noncontributory NN B-NP O
to TO B-PP O
this DT B-NP O
admission NN I-NP B-DATE
. . O O
SOCIAL JJ B-NP O
HISTORY NN I-NP B-DATE
General NNP B-NP O
&#8211 CD I-NP O
; : O O
lives NNS B-NP O
with IN B-PP O
husband NN B-NP O
and CC I-NP O
grandchildren NNS I-NP B-DOCTOR
Tobacco NNP B-NP O
&#8211 CD I-NP O
; : O O
used VBN B-VP I-DATE
to TO I-VP I-DATE
smoke VB I-VP O
1.5-2 CD B-NP O
pack/day NN I-NP O
, , O O
quit VB B-VP O
12 CD B-NP O
years NNS I-NP O
ago IN B-PP O
EtOH NNP B-NP O
&#8211 CD I-NP O
; : O O
none NN B-NP O
IVDU NNP B-NP O
&#8211 CD I-NP O
; : O O
none NN B-NP O
ALLERGIES NNS B-NP O
: : O I-DATE
Penicillins NNP B-NP I-DATE
( -LRB- I-NP O
Rash NN I-NP O
) -RRB- O O
TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP O
( -LRB- I-NP O
Rash NN I-NP O
) -RRB- O O
OMEPRAZOLE JJ B-NP O
( -LRB- I-NP O
Possible JJ I-NP O
acute JJ I-NP O
interstitial JJ I-NP O
nephritis NN I-NP O
) -RRB- O O
MEDICATIONS NNS B-NP O
ON IN B-PP O
ADMISSION NN B-NP O
1 LS O O
. . B-NP O
Acetylsalicylic NNP I-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
2. . B-NP O
Albuterol NNP I-NP O
Inhaler NNP I-NP O
Hfa NNP I-NP O
2 CD I-NP O
PUFF NN I-NP O
INH IN B-PP O
Q6H NNP B-NP O
prn NN I-NP O
Wheezing VBG I-NP O
3. . B-NP O
Amlodipine NNP I-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
4 CD B-LST O
. . O O
Clonazepam NNP B-NP O
0.25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
5 CD B-NP O
. . O O
Fenofibrate NNP O O
( -LRB- O O
Tricor NNP B-NP O
) -RRB- I-NP O
145 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
6 CD B-NP O
. . O O
Fluoxetine NNP B-NP O
Hcl NNP I-NP O
( -LRB- O O
Prozac NNP B-NP O
) -RRB- I-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
7. . B-NP O
Fluticasone NNP I-NP O
Prop/Salmeterol NNP I-NP O
500/50 CD I-NP O
( -LRB- I-NP O
Advair NNP I-NP O
Diskus NNP I-NP O
500/50 CD I-NP O
) -RRB- I-NP O
1 CD I-NP O
INHALATION NN I-NP O
INH NNP I-NP O
BID NNP I-NP O
8. CD B-NP O
Furosemide NNP I-NP O
( -LRB- I-NP O
Lasix NNP I-NP O
) -RRB- I-NP O
80 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
9 CD B-NP O
. . O O
Insulin NNP B-NP O
Aspart NNP I-NP O
70/30 CD I-NP O
Pen NNP I-NP O
( -LRB- I-NP O
Novolog NNP I-NP O
70/30 CD I-NP O
Flexpen NNP I-NP O
) -RRB- I-NP O
40 CD I-NP O
UNITS NNP I-NP O
SC NNP I-NP O
10 CD B-NP O
. . O O
Kcl NNP B-NP O
Slow NNP I-NP O
Release NNP I-NP O
Tab NNP I-NP O
20 CD I-NP O
MEQ NNP I-NP O
PO NNP I-NP O
QD . O O
11 CD B-NP O
. . O O
Ketoconazole NNP B-NP O
1 CD I-NP O
APPLICATION NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
12 CD B-NP O
. . O O
Levothyroxine NNP B-NP O
Sodium NNP I-NP O
( -LRB- I-NP O
Levoxyl NNP I-NP O
) -RRB- I-NP O
175 CD I-NP O
MCG NNP I-NP O
PO NNP I-NP O
QD . O O
Dr. NNP B-NP O
Uy NNP I-NP O
signing NN I-NP O
for IN B-PP O
Dr. NNP B-NP O
Arthur NNP I-NP O
Qin NNP I-NP O
13 CD B-NP O
. . O O
Lidocaine NNP B-NP O
5 CD B-NP O
% NN I-NP O
Patch NNP B-NP O
1 CD I-NP O
PATCH NNP I-NP O
TRANSDERMAL NNP I-NP O
QD . O O
14 CD B-NP O
. . O O
Lisinopril NNP B-PP O
2.5 CD B-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
15 CD B-NP O
. . O O
Medroxyprogesterone NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
16 CD B-NP O
. . O O
Metformin NNP B-NP O
Extended NNP I-NP O
Release NNP I-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
17 CD B-NP O
. . O O
Metolazone NNP B-PP O
2.5 CD B-NP O
MG NNP I-NP O
PO NNP I-NP O
AS NNP I-NP O
DIRECTED NNP I-NP O
please VBP B-VP O
take VB I-VP O
half NN B-NP O
an DT B-NP O
hour NN I-NP O
before IN B-PP O
morning NN B-NP O
lasix NN I-NP O
dose NN I-NP O
twice RB B-ADVP O
a DT B-NP O
week NN I-NP O
, , O O
on IN B-PP O
Thursday NNP B-NP O
and CC I-NP O
Sunday NNP I-NP O
18 CD B-NP O
. . O O
Metoprolol NNP B-NP O
Succinate NNP I-NP O
Extended NNP I-NP O
Release NNP I-NP O
( -LRB- I-NP O
Toprol NNP I-NP O
Xl NNP I-NP O
) -RRB- I-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
19 CD B-NP O
. . O O
Morphine NNP B-NP O
Controlled NNP I-NP O
Release NNP I-NP O
30 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q12H NNP I-NP O
prn NN I-NP O
back RB B-ADVP O
pain NN O O
20 CD B-NP O
. . O O
Nystatin NNP B-NP O
Powder NNP I-NP O
1 CD I-NP O
APPLICATION NNP I-NP O
TOP NNP I-NP O
BID NNP I-NP O
21 CD B-NP O
. . O O
Oxycodone NNP B-NP O
5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q12H NNP I-NP O
prn NN I-NP O
pain NN I-NP O
22 CD B-NP O
. . O O
Phenazopyridine NNP B-NP O
Hcl NNP I-NP O
( -LRB- I-NP O
Pyridium NN I-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
please VB B-VP O
take VB I-VP O
AFTER NNP B-NP O
meals NNS I-NP O
23 CD B-NP O
. . O O
Prednisone NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
24 CD B-NP O
. . O O
Pregabalin NNP O O
( -LRB- O O
Lyrica NNP B-NP O
) -RRB- I-NP O
50 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
25 CD B-LST O
. . O O
Sennosides NNPS B-VP O
( -LRB- I-VP O
Senna NNP B-NP O
Tablets NNP I-NP O
) -RRB- I-NP O
2 CD I-NP O
TAB NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
prn NN I-NP O
Constipation NN I-NP O
26 CD B-NP O
. . O O
Simvastatin NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QPM NNP I-NP O
take VB B-VP O
one CD B-NP O
po NN I-NP O
daily RB B-SBAR O
27 CD B-NP O
. . O O
Tiotropium NNP B-NP O
18 CD I-NP O
MCG NNP I-NP O
INH NNP I-NP O
QD . O O
28 CD B-NP O
. . O O
Trazodone NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS NNP I-NP O
prn NN I-NP O
Insomnia . O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
VITALS NNS B-NP O
: : O O
T NNP B-NP O
: : O O
99.2 CD B-NP O
P NNP I-NP O
: : O O
91 CD O O
BP NNP B-NP O
: : O O
98/63 CD B-NP O
RR NN I-NP O
: : O O
22 CD O O
SpO2 NNP B-NP O
: : O O
98 CD B-NP O
% NN I-NP O
2.5L CD I-NP O
NC NNP I-NP O
GEN&#8217;L NNP B-NP O
: : O O
Obese NNP B-NP O
, , O O
tearful JJ B-NP O
woman NN I-NP O
reclining VBG B-VP O
flat JJ B-ADJP O
in IN B-PP O
bed NN B-NP O
HEENT NNP B-NP O
: : O O
EOMI NNP B-NP O
, , O O
PERRL. . O O
NECK NNP B-NP O
: : O O
Supple NNP B-NP O
. . O O
Could MD B-VP O
not RB I-VP O
appreciate VB I-VP O
IJ. NNP B-NP O
No DT B-NP O
lymphadenopathy NN I-NP O
. . O O
Heart NNP B-NP O
: : O O
RRR NNP B-NP O
. . O O
No DT B-NP O
m/r/g NN I-NP O
. . O O
LUNG NNP B-NP O
: : O O
Exam NNP B-NP O
limited VBN B-VP O
by IN B-PP O
obesity NN B-NP O
( -LRB- I-NP I-DOCTOR
could MD B-VP I-DOCTOR
not RB I-VP O
sit VB I-VP O
up RP B-ADVP O
for IN B-PP O
full JJ B-NP O
posterior JJ I-NP B-DOCTOR
exam NN I-NP I-DOCTOR
) -RRB- I-NP O
, , O O
but CC O O
I PRP B-NP O
could MD B-VP O
not RB I-VP O
appreciate VB I-VP O
any DT B-NP O
wheezes NNS I-NP O
or CC I-NP O
crackles NNS I-NP O
. . O O
ABD NNP B-NP O
: : O O
Obese NNP B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
non-tender JJ I-NP O
. . I-NP O
Bowel NNP I-NP O
sounds VBZ B-VP O
present JJ B-ADJP O
. . O O
EXT NNP B-NP O
: : O O
Changes NNS B-NP O
c/w VBP B-VP O
venous JJ B-NP O
stasis NN I-NP O
; : O O
trace NN B-NP O
bilateral JJ I-NP O
ankle NN I-NP O
edema NN I-NP O
. . O O
LABS NNP B-NP O
: : O O
Plasma NNP B-NP O
Sodium NNP I-NP O
138 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
3.6 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
89 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
39.8 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Anion NNP I-NP O
GAP NNP I-NP O
9 CD I-NP O
(3-15 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Calcium NNP B-NP O
9.8 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus NNP B-NP O
4.4 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP B-DATE
1.8 CD I-NP O
( -LRB- O I-DATE
1.4-2.0) CD B-NP I-DATE
meq/L NN I-NP O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
51 CD I-NP O
H NNP B-NP O
(8-25 . O O
) -RRB- O O
mg/dl . O O
Plasma NNP B-NP O
Creatinine VBZ B-VP O
1.04 CD B-NP O
( -LRB- I-NP O
0.60-1.50 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
eGFR NN B-NP O
57 CD I-NP O
mL/min/1.73m2 . O O
Plasma NNP B-NP O
Glucose NNP I-NP O
183 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Protein NNP I-NP O
7.4 CD I-NP O
( -LRB- I-NP O
6.0-8.3 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Albumin NNP B-NP O
3.9 CD I-NP O
( -LRB- O O
3.3-5.0) CD B-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
3.5 CD I-NP O
( -LRB- I-NP O
2.3-4.1 CD B-NP O
) -RRB- I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.2 CD I-NP O
(0-0.4 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.5 CD I-NP O
( -LRB- B-VP O
0.0-1.0) CD B-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
88 CD I-NP O
( -LRB- I-NP O
30-100 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGPT NNP B-NP O
13 CD I-NP O
(7-30 CD I-NP O
) -RRB- I-NP O
U/L . O O
NT-proBNP JJ B-NP O
42 CD I-NP O
(0-900 CD I-NP O
) -RRB- I-NP O
pg/ml . O O
Transaminase-SGOT JJ B-NP O
15 CD I-NP O
( -LRB- I-NP O
9-32 CD I-NP O
) -RRB- I-NP O
U/L . O O
Lipase NNP B-NP O
20 CD I-NP O
( -LRB- I-NP O
13-60 CD I-NP O
) -RRB- I-NP O
U/L . O O
WBC NNP B-NP O
13.0 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
32.8 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
36.0-46.0) CD I-NP O
% NN I-NP O
HGB NNP B-NP O
11.0 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
12.0-16.0) JJ I-NP O
gm/dl NN I-NP O
RBC NNP B-NP O
4.13 CD I-NP O
( -LRB- I-NP O
4.00-5.20 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NNP B-NP O
286 CD I-NP O
( -LRB- I-NP O
150-400 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
80 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
26.5 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
33.4 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
17.6 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Diff JJ B-NP O
Method NNP I-NP O
Auto NN I-NP O
Poly NNP B-NP O
85 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
8 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NNP B-NP O
6 CD I-NP O
( -LRB- I-NP O
4-11 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
(0-8 CD I-NP O
) -RRB- O O
% NN O O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
MICROBIOLOGY NNP B-NP O
: : O O
Blood NN B-NP O
cultures NNS I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
from IN B-SBAR O
ED VBN B-VP O
on IN B-PP O
3/4 CD B-NP O
pending VBG I-NP O
No DT B-NP O
respiratory NN I-NP O
sample NN I-NP O
sent VBD B-VP O
. . O O
RADIOLOGY NNP B-NP O
: : O O
CXR NN B-NP O
( -LRB- I-NP O
3/4 CD I-NP O
) -RRB- I-NP O
: : O O
RLL JJ B-NP O
patchy JJ I-NP O
opacity NN I-NP O
. . O O
ASSESSMENT NNP B-NP O
&amp; NNP I-NP O
PLAN NNP I-NP O
64 CD B-NP O
year-old JJ I-NP O
morbidly JJ I-NP O
obese JJ I-NP O
woman NN I-NP O
with IN B-PP O
DM2 NNP B-NP O
, , O O
OSA NNP B-NP O
, , O O
COPD NNP B-NP O
on IN B-PP O
2.5L JJ B-NP O
home NN I-NP O
O2 NNS I-NP O
, , O O
OSA NNP B-NP O
, , O O
recently RB B-VP O
treated VBN I-VP O
for IN B-PP O
influenza NN B-NP O
A DT B-NP O
, , O O
presents VBZ B-VP O
with IN B-PP O
persistent JJ B-NP O
cough NN I-NP O
productive JJ B-ADJP O
of IN B-PP O
green NN B-NP O
sputum NN I-NP O
and CC I-NP O
rib NN I-NP O
pain NN I-NP O
. . O O
# # B-NP O
) -RRB- I-NP O
Productive JJ I-NP O
cough NN I-NP O
: : O O
Has VBZ B-VP O
leukocytosis NN B-NP O
and CC I-NP O
haziness NN I-NP O
especially RB B-ADVP O
on IN B-PP O
lateral JJ B-NP O
CXR NN I-NP O
. . O O
In IN B-PP O
the DT B-NP O
absence NN I-NP O
of IN B-PP O
other JJ B-NP O
symptoms NNS I-NP O
( -LRB- B-NP O
new JJ I-NP O
O2 NN I-NP O
requirement NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
fevers/chills NNS B-NP O
) -RRB- B-VP O
, , O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
pneumonia NN B-NP O
is VBZ B-VP O
difficult JJ B-ADJP O
to TO B-VP O
make VB I-VP O
. . O O
However RB B-ADVP O
, , O O
she PRP B-NP O
is VBZ B-VP O
on IN B-PP O
chronic JJ B-NP O
steroids NNS I-NP O
and CC I-NP O
narcotics NNS I-NP O
at IN B-PP O
baseline NN B-NP O
and CC O O
may MD B-VP O
not RB I-VP O
mount VB I-VP O
a DT B-NP O
typical JJ I-NP O
symptomatic JJ I-NP O
response NN I-NP O
. . O O
- : O O
Continue JJ B-NP O
HAP NNP I-NP O
coverage NN I-NP O
started VBD B-VP O
in IN B-PP O
ED JJ B-NP O
(vanc+cef NN I-NP O
) -RRB- O O
for IN B-PP O
seven CD B-NP O
days NNS I-NP O
- : O O
Respiratory NN B-NP O
cultures NNS I-NP O
ordered VBN O O
# # B-NP O
) -RRB- I-NP O
Multiple NNP I-NP O
re-hospitalizations NNS I-NP O
: : O O
as IN B-PP O
above RB B-NP O
, , O O
she PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
admitted VBN I-VP O
at IN B-PP O
ten CD B-NP O
times NNS I-NP O
in IN B-PP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
just RB B-ADVP O
to TO B-VP O
MCH VB I-VP O
alone RB B-ADVP O
. . O O
A DT B-NP O
viable JJ I-NP O
long-term JJ I-NP O
plan NN I-NP O
for IN B-PP O
outpatient JJ B-NP O
management NN I-NP O
is VBZ B-VP O
essential JJ B-ADJP O
. . O O
- : O O
Consider VB B-VP O
complex JJ B-NP O
care NN I-NP O
committee NN I-NP O
consult VB B-VP O
this DT B-NP O
admission NN I-NP O
# # B-NP O
) -RRB- I-NP O
Prophy NNP I-NP O
: : O O
Fragmin NNP B-NP O
5000 CD I-NP O
; : O O
senna+colace NN B-NP O
; : O O
H2 CD B-NP O
blocker NN I-NP O
( -LRB- I-NP O
given VBN I-NP O
chronic NN I-NP O
steroid NN I-NP O
use NN I-NP O
) -RRB- O O
# # B-NP O
) -RRB- I-NP O
F/E/N NNP I-NP O
: : O O
regular JJ B-NP O
diet NN I-NP O
. . O O
Delbert NNP B-NP O
Lyles NNP I-NP O
, , O O
MD NNP B-NP O
, , O O
PhD NNP B-NP O
, , O O
PGY-1 NNP B-NP O
, , O O
pager NN B-NP O
: : O O
50645 CD O O
